CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 46 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $229,000 | +0.4% | 12,457 | 0.0% | 0.01% | -18.2% |
| Q3 2020 | $228,000 | +45.2% | 12,457 | +18.8% | 0.01% | +37.5% |
| Q2 2020 | $157,000 | -25.2% | 10,482 | -21.1% | 0.01% | -42.9% |
| Q1 2020 | $210,000 | -26.1% | 13,282 | -24.0% | 0.01% | -22.2% |
| Q4 2019 | $284,000 | +54.3% | 17,479 | +41.3% | 0.02% | +12.5% |
| Q3 2019 | $184,000 | – | 12,373 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| S. MUOIO & CO. LLC | 40,000 | $734,000 | 0.83% |
| WATER ISLAND CAPITAL LLC | 133,286 | $2,444,000 | 0.21% |
| Walleye Capital LLC | 90,666 | $1,663,000 | 0.18% |
| GLAZER CAPITAL, LLC | 202,158 | $3,708,000 | 0.18% |
| First Trust Capital Management L.P. | 35,613 | $653,000 | 0.18% |
| EQUITEC PROPRIETARY MARKETS, LLC | 12,500 | $229,000 | 0.18% |
| EQUITEC PROPRIETARY MARKETS, LLC | 10,600 | $194,000 | 0.15% |
| Olympiad Research LP | 13,484 | $247,000 | 0.13% |
| Yakira Capital Management, Inc. | 17,588 | $323,000 | 0.10% |
| Alpine Global Management, LLC | 25,000 | $459,000 | 0.10% |